Fetal Outcome from Prolonged Versus Acute Drug Administration in the Pregnant Rat

  • C. T. G. King
  • E. Horigan
  • A. L. Wilk
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 27)


Eleven years ago last May (1), our distinguished opening lecturer, Dr. Josef Warkany, called to order the first meeting of the Teratology Society of the USA in Cleveland, Ohio. He did this after years of work in the field of pediatrics and experimental teratology, observing many malformed children in his clinical practice. At that time, he requested that workers in other areas of biomedical sciences join in the search for the causes of congenital malformation and the mode of action of the causative agents as an approach to the prevention and cure of such malformation. Nine years later (2), at the close of the Third International Conference on Congenital Malformations, he expressed his satisfaction in seeing “so many talented investigators, representative of so many sciences, turn to this once neglected field of medicine” and emphasized that “our aim must be the prevention of congenital malformations”. At the present, as in 1969, we are still at the beginning of preventive teratology; however, since 1961, the time of our first meeting, there is an ever-increasing number of scientists aware of the problems of congenital malformations. This awareness was probably brought about by the teratogenic effects of thalidomide. But thalidomide or not, such an incident was bound to happen with our constant development of new drugs to combat diseases that plague mankind.


Congenital Malformation Club Foot Cleft Palate Cleave Palate Palatal Shelf 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    WARKANY, J. First Teratology Society Meeting, Cincinnati, Ohio, 1960.Google Scholar
  2. 2.
    WARKANY, J. Congenital Malformations, The Hague, September 1969.Google Scholar
  3. 3.
    KING, C.T.G., WEAVER, S.A. and DERR, J.E. Am. J. Obstet. and Gynecol. 93: 4, 1965.Google Scholar
  4. 4.
    KING, C.T.G., WEAVER, S.A. and NARROD, S.A. The J. of Pharm. and Exper. Therapeutics 147: 3, 1965.Google Scholar
  5. 5.
    KING, C.T.G. Environmental Variables in Oral Diseases, ed. by S.J. Kreshover and F.J. McClure, pp. 241–258. American Assoc. for the Adv. of Science. Washington, D.C., 1966.Google Scholar
  6. 6.
    KING, C.T.G., HOWELL, J. Am. J. Obstet. and Gynecol. 95: 1, 1966.Google Scholar
  7. 7.
    WILK, A.L., KING, C.T.G, ET AL. The J. of Pharmacology and Exper. Therapeutics 171: 1, 1970.Google Scholar
  8. 8.
    WILK, A.L., KING, C.T.G., ET AL. Teratology. In press.Google Scholar
  9. 9.
    STEFFEK, A.J., VERUSSIO, A. C. and WATKINS, C.A. Teratology. In press.Google Scholar
  10. 10.
    PRATT, R.M., JR. and KING, C.T.G. Archives of Oral Biology 16: 10, 1971.CrossRefGoogle Scholar
  11. 11.
    PRATT, R.M., JR. E1 KING, C.T.G. Developmental Biology. In press.Google Scholar
  12. 12.
    ABRAMOVICH,A. and DEVOTO, F.C. Archives of Oral Biology 13: 823, 1968.PubMedCrossRefGoogle Scholar
  13. 13.
    LEVENE, C.I. J. Exper. Mid. 114: 295, 1961.CrossRefGoogle Scholar
  14. 14.
    MARTIN, G.R., MECCA, C.E. and PIEZ, K.A. Environmental Variables in Oral Diseases. (Ed. S.J. Kreshover and F.J. McClure) Am. Assoc. for the Adv. of Sci. Washington, D.C. 1966.Google Scholar
  15. 15.
    TUCHMANN-DUPLESSIS, M.H. and MERCIER-PAROT, M.L. Conrpt. Rend. Acad. Sc. 256: 3359, 1963.Google Scholar

Copyright information

© Plenum Press, New York 1972

Authors and Affiliations

  • C. T. G. King
    • 1
  • E. Horigan
    • 1
  • A. L. Wilk
    • 1
  1. 1.National Institute of Dental ResearchNational Institutes of HealthBethesdaUSA

Personalised recommendations